Figures index

From

Comparison of Infectious Complications with BCMA-Directed Therapies in Multiple Myeloma

Haylaa Parqi, Dahbah Alkaabi, Saadah Tanoon, Kholod Naseri, Azizah Aljwen, Meshal Alotaibi, Laila Alsulobi

American Journal of Medical and Biological Research. 2024, 12(2), 73-80 doi:10.12691/ajmbr-12-2-6
  • Figure 1. Baseline characteristics of patients who received T-cell redirecting therapies
  • Figure 2. Functional serum IgG levels over time after treatment initiation up to 6 months of follow up
  • Figure 3. Absolute neutrophil count over time after treatment initiation up to 6 months of follow up